20/20 Biolabs, Inc.
Company Information
Industry
Services-Testing Laboratories
SIC Code
8734
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
9430 KEY WEST AVENUE, ROCKVILLE, MD, 20850
Mailing Address
15810 GAITHER ROAD, SUITE 235, GAITHERSBURG, MD, 20877
Phone
2404536339
Fiscal Year End
1231
EIN
522272107
Financial Overview
FY2025
$4.14M
Total Assets
$4.16M
Total Liabilities
$1.78M
Cash & Equivalents
$-0.76
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 10, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 25, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
| 3 Initial insider ownership report | February 23, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
IPO Filings
S-1
December 12, 2025
- Focus on developing advanced diagnostic tests for early disease detection, particularly in infectious diseases and certain types of cancer.
- Demonstrating steadily increasing year-over-year sales and expanding into new markets.
Annual Reports
10-K
March 31, 2026
- Cancer testing revenue surged 457% from 2022 to 2025.
- Proprietary AI trained on 2.5 million health records achieves 85% detection accuracy.
Related Companies
Companies in the same industry (SIC: 8734)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.